ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Business/EarningsArticle

Dutch insurer ASR Nederland posts 9.8% H1 operating profit rise

Net profit surged to €809 million as real estate revaluations and rate moves offset costs, while fee-based businesses grew 32% on HumanTotalCare acquisition.

PA
Priya Anand · Equities & Earnings Desk · 20 Aug 2026 · 09:13 · 1 min read
Share
Dutch insurer ASR Nederland posts 9.8% H1 operating profit rise

Dutch insurer ASR Nederland reported a 9.8% increase in first-half operating profit to €901 million, driven by growth in its life insurance segment and fee-based businesses. The company’s net profit rose more than fivefold to €809 million from €126 million a year earlier, boosted by favorable real estate revaluations and interest rate movements.

The life segment, ASR’s largest, posted an 11.6% rise in operating profit to €689 million, supported by a higher investment margin and reduced drag from the ultimate forward rate. The non-life segment saw a 4.6% increase in operating profit to €268 million, with a combined ratio of 91.6% excluding health insurance, slightly above the prior year’s 91.4% but within the group’s 92–94% target range.

Fee-based businesses surged 32.1%, primarily due to the acquisition of HumanTotalCare. The operating return on equity improved to 15.4% from 14.2%, exceeding the company’s 12% target. ASR’s Solvency II capital adequacy ratio rose to 222% from 218% at year-end 2025.

Organic capital creation increased 7.3% to €773 million, supported by dividend payments and a €175 million share buyback completed in the period. The interim dividend was raised by 9.4% to €1.39 per share.

The results cover the six months ended June 30.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT